China Health Industries Holdings, Inc. (CHHE) Financial Statements (2025 and earlier)
Company Profile
Business Address |
3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HEILONGJIANG PROVINCE, 150028 |
State of Incorp. | |
Fiscal Year End | June 30 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
3/31/2024 MRQ | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 47,246 | 44,789,999 | 44,346,744 | 36,072,474 | 35,507,535 | 32,614,910 | |||
Cash and cash equivalent | 47,246 | 44,789,999 | 44,346,744 | 36,072,474 | 35,507,535 | 32,614,910 | |||
Receivables | 1,921 | 41,345 | 2,379,717 | 4,664,116 | 2,015,940 | 1,486,044 | |||
Inventory, net of allowances, customer advances and progress billings, including: | 40,608 | 521,229 | 761,639 | 807,351 | 857,239 | 160,394 | |||
Inventory | 40,608 | 521,229 | 761,639 | 807,351 | 857,239 | 452,397 | |||
Other undisclosed inventory, net of allowances, customer advances and progress billings | (292,003) | ||||||||
Prepaid expense | 40,682,360 | 30,004 | 24,466 | 41,505 | 15,868 | 20,462 | |||
Advances on inventory purchases | |||||||||
Other undisclosed current assets | 198,157 | 214,915 | 218,307 | 205,650 | 8,619 | 386,752 | |||
Total current assets: | 40,970,292 | 45,597,492 | 47,730,873 | 41,791,096 | 38,405,201 | 34,668,562 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 2,727,170 | 3,158,021 | 3,629,905 | 3,677,798 | 3,719,424 | 3,724,490 | |||
Long-term investments and receivables | 9,567 | ||||||||
Accounts and financing receivable, after allowance for credit loss | 9,567 | ||||||||
Intangible assets, net (including goodwill) | 964,775 | 1,412,603 | 1,963,516 | 2,249,614 | 2,782,869 | 3,372,501 | |||
Intangible assets, net (excluding goodwill) | 964,775 | 1,412,603 | 1,963,516 | 2,249,614 | 2,782,869 | 3,372,501 | |||
Prepaid expense | 9,709 | 30,212 | |||||||
Deferred income tax assets | 2,933 | 5,806 | ✕ | ✕ | |||||
Other undisclosed noncurrent assets | 420,092 | 569,835 | 560,910 | 511,664 | 837,687 | 1,136,804 | |||
Total noncurrent assets: | 4,112,037 | 5,150,026 | 6,157,264 | 6,444,882 | 7,349,689 | 8,264,007 | |||
TOTAL ASSETS: | 45,082,329 | 50,747,518 | 53,888,137 | 48,235,978 | 45,754,890 | 42,932,569 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 286,902 | 334,972 | 406,821 | 406,228 | 497,084 | 400,109 | |||
Taxes payable | ✕ | ✕ | 176,359 | 425,106 | 619,403 | 428,423 | |||
Employee-related liabilities | ✕ | ✕ | 218,602 | 275,982 | 265,686 | 234,668 | |||
Accrued liabilities | 228,575 | 295,436 | |||||||
Other undisclosed accounts payable and accrued liabilities | 58,327 | 39,536 | 11,860 | (294,860) | (388,005) | (262,982) | |||
Debt | 94,293 | ||||||||
Due to related parties | ✕ | 6,759,761 | 8,079,761 | 7,259,862 | 6,962,520 | 6,393,730 | |||
Other undisclosed current liabilities | 5,591,565 | 850,066 | 626,914 | 901,902 | 1,112,823 | 894,350 | |||
Total current liabilities: | 5,972,760 | 7,944,799 | 9,113,496 | 8,567,992 | 8,572,427 | 7,688,189 | |||
Noncurrent Liabilities | |||||||||
Total liabilities: | 5,972,760 | 7,944,799 | 9,113,496 | 8,567,992 | 8,572,427 | 7,688,189 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 39,109,569 | 42,802,719 | 44,774,641 | 39,667,986 | 37,182,463 | 35,244,380 | |||
Common stock | 6,554 | 6,554 | 6,554 | 6,554 | 6,554 | 6,554 | |||
Additional paid in capital | 521,987 | 521,987 | 521,987 | 521,987 | 521,987 | 521,987 | |||
Accumulated other comprehensive income (loss) | (2,745,558) | 538,820 | 2,156,792 | (1,658,741) | (593,654) | 775,302 | |||
Retained earnings | 41,287,907 | 41,696,679 | 42,050,629 | 40,759,507 | 37,208,897 | 33,901,858 | |||
Other undisclosed equity, attributable to parent | 38,679 | 38,679 | 38,679 | 38,679 | 38,679 | 38,679 | |||
Total equity: | 39,109,569 | 42,802,719 | 44,774,641 | 39,667,986 | 37,182,463 | 35,244,380 | |||
TOTAL LIABILITIES AND EQUITY: | 45,082,329 | 50,747,518 | 53,888,137 | 48,235,978 | 45,754,890 | 42,932,569 |
Income Statement (P&L) (USD)
3/31/2024 TTM | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 111,579 | 267 | 6,492,720 | 9,931,887 | 9,275,386 | 6,554,939 | ||
Net investment income | 113,615 | 157,860 | 137,485 | 125,627 | 114,228 | 110,591 | ||
Cost of revenue | (111,359) | (1,748) | (2,850,729) | (2,657,044) | (2,238,011) | (4,279,635) | ||
Cost of product and service sold | (2,238,011) | |||||||
Gross profit: | 220 | (1,481) | 3,641,991 | 7,274,843 | 7,037,375 | 2,275,304 | ||
Operating expenses | (1,842,821) | (1,646,442) | (1,778,083) | (2,382,748) | (2,475,457) | (2,742,162) | ||
Operating income (loss): | (1,842,601) | (1,647,923) | 1,863,908 | 4,892,095 | 4,561,918 | (466,858) | ||
Nonoperating income | 1,433,829 | 1,296,907 | 157,675 | 124,875 | 128,784 | 413,096 | ||
Other nonoperating income (expense) | 1,320,791 | 1,139,746 | 20,972 | 45 | 15,681 | 353,461 | ||
Interest and debt expense | (1) | (6) | (49,408) | |||||
Other undisclosed income from continuing operations before equity method investments, income taxes | 1 | 6 | 49,408 | |||||
Income (loss) from continuing operations before equity method investments, income taxes: | (408,772) | (351,016) | 2,021,583 | 5,016,970 | 4,690,702 | (53,762) | ||
Other undisclosed income from continuing operations before income taxes | ||||||||
Income (loss) from continuing operations before income taxes: | (408,772) | (351,016) | 2,021,583 | 5,016,970 | 4,690,702 | (53,762) | ||
Income tax expense | (2,934) | (730,461) | (1,466,360) | (1,383,663) | (263,065) | |||
Income (loss) from continuing operations: | (408,772) | (353,950) | 1,291,122 | 3,550,610 | 3,307,039 | (316,827) | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | 1,291,122 | 3,550,610 | 3,307,039 | (316,827) | |
Net income (loss) available to common stockholders, diluted: | (408,772) | (353,950) | 1,291,122 | 3,550,610 | 3,307,039 | (316,827) |
Comprehensive Income (USD)
3/31/2024 TTM | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (408,772) | (353,950) | 1,291,122 | 3,550,610 | 3,307,039 | (316,827) | ||
Other comprehensive income (loss) | (3,284,378) | (1,617,972) | 3,815,533 | (1,065,087) | (1,368,956) | 853,351 | ||
Comprehensive income (loss): | (3,693,150) | (1,971,922) | 5,106,655 | 2,485,523 | 1,938,083 | 536,524 | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 536,524 | |||||||
Comprehensive income (loss), net of tax, attributable to parent: | (3,693,150) | (1,971,922) | 5,106,655 | 2,485,523 | 1,938,083 | 1,073,048 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.